ICGCT 0 5 0 5 B-cancer
including 6 15 6 15 O
pure 16 20 16 20 O
germinoma 21 30 21 30 B-cancer
and 31 34 31 34 O
MMGCT 35 40 35 40 B-cancer

Patient 0 7 41 48 O
with 8 12 49 53 O
ONLY 13 17 54 58 O
mature 18 24 59 65 O
and/or 25 31 66 72 O
immature 32 40 73 81 O
teratoma 41 49 82 90 B-cancer
are 50 53 91 94 O
ineligible 54 64 95 105 O
in 65 67 106 108 O
the 68 71 109 112 O
absence 72 79 113 120 O
of 80 82 121 123 O
the 83 86 124 127 O
tumor 87 92 128 133 B-cancer
marker 93 99 134 140 O
elevations 100 110 141 151 O

Patients 0 8 152 160 O
who 9 12 161 164 O
are 13 16 165 168 B-pregnancy
pregnant 17 25 169 177 I-pregnancy

Patients 0 8 178 186 O
who 9 12 187 190 O
have 13 17 191 195 O
received 18 26 196 204 O
gemcitabine 27 38 205 216 B-treatment
, 38 39 216 217 O
oxaliplatin 40 51 218 229 B-treatment
and/or 52 58 230 236 O
paclitaxel 59 69 237 247 B-treatment

Patients 0 8 248 256 O
who 9 12 257 260 O
have 13 17 261 265 O
received 18 26 266 274 O
previously 27 37 275 285 O
a 38 39 286 287 O
high 40 44 288 292 O
dose 45 49 293 297 O
chemotherapy 50 62 298 310 B-treatment
regimen 63 70 311 318 O
and 71 74 319 322 O
autologous 75 85 323 333 B-treatment
transplant 86 96 334 344 I-treatment

Patients 0 8 345 353 O
with 9 13 354 358 O
ICGCTs 14 20 359 365 B-cancer
who 21 24 366 369 O
are 25 28 370 373 O
newly 29 34 374 379 O
diagnosed 35 44 380 389 O

Patients 0 8 390 398 O
with 9 13 399 403 O
histologically 14 28 404 418 O
proven 29 35 419 425 O
germinoma 36 45 426 435 B-cancer
and 46 49 436 439 O
MMGCT 50 55 440 445 B-cancer
, 55 56 445 446 O
including 57 66 447 456 O
endodermal 67 77 457 467 B-cancer
sinus 78 83 468 473 I-cancer
tumor 84 89 474 479 I-cancer
( 90 91 480 481 O
yolk 91 95 481 485 B-cancer
sac 96 99 486 489 I-cancer
tumor 100 105 490 495 I-cancer
) 105 106 495 496 O
, 106 107 496 497 O
embryonal 108 117 498 507 B-cancer
carcinoma 118 127 508 517 I-cancer
, 127 128 517 518 O
choriocarcinoma 129 144 519 534 B-cancer
and 145 148 535 538 O
mixed 149 154 539 544 B-cancer
germ 155 159 545 549 I-cancer
cell 160 164 550 554 I-cancer
tumor 165 170 555 560 I-cancer

Patients 0 8 561 569 O
with 9 13 570 574 O
mature 14 20 575 581 B-cancer
/ 20 21 581 582 I-cancer
immature 21 29 582 590 I-cancer
teratoma 30 38 591 599 I-cancer
who 39 42 600 603 O
have 43 47 604 608 O
tumor 48 53 609 614 B-cancer
marker 54 60 615 621 O
elevations 61 71 622 632 O

Patients 0 8 633 641 O
with 9 13 642 646 O
the 14 17 647 650 O
diagnosis 18 27 651 660 O
of 28 30 661 663 O
mature 31 37 664 670 B-cancer
or 38 40 671 673 O
immature 41 49 674 682 B-cancer
teratoma 50 58 683 691 I-cancer
in 59 61 692 694 O
the 62 65 695 698 O
absence 66 73 699 706 O
of 74 76 707 709 O
tumor 77 82 710 715 B-treatment
marker 83 89 716 722 I-treatment
elevations 90 100 723 733 I-treatment

